What's breaking now, across thousands of outlets.
Curium has set the list price for Bexlutry, its radiosimilar to Novartis’ Lutathera, at $63,524 per infusion — about a 5% discount to the cost of the pharma giant’s drug. Challenging Novartis in the tricky field ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common liver condition that can follow very different paths among patients.
Vaccination not only prevents disease caused by acute infection but also protects against long-term immune-related sequelae that can follow an acute viral infection.
Ghana is expected to produce its first locally manufactured vaccine by 2027, with production processes currently underway at Atlantic Lifesciences Limited.
The latest news from CMS, HHS and more across Washington, D.C.
Judith Lucy's breast cancer diagnosis means she has joined a club nobody wants to be a part of. A survivor tells how humour and resilience can make the journey easier.
Semi-annual redeterminations and work requirements will test payer-mix assumptions across the industry over the next two years.
